Sequence logic at enhancers governs a dual mechanism of endodermal organ fate induction by FOXA pioneer factors.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
17 11 2021
Historique:
received: 29 10 2020
accepted: 28 10 2021
entrez: 18 11 2021
pubmed: 19 11 2021
medline: 16 12 2021
Statut: epublish

Résumé

FOXA pioneer transcription factors (TFs) associate with primed enhancers in endodermal organ precursors. Using a human stem cell model of pancreas differentiation, we here discover that only a subset of pancreatic enhancers is FOXA-primed, whereas the majority is unprimed and engages FOXA upon lineage induction. Primed enhancers are enriched for signal-dependent TF motifs and harbor abundant and strong FOXA motifs. Unprimed enhancers harbor fewer, more degenerate FOXA motifs, and FOXA recruitment to unprimed but not primed enhancers requires pancreatic TFs. Strengthening FOXA motifs at an unprimed enhancer near NKX6.1 renders FOXA recruitment pancreatic TF-independent, induces priming, and broadens the NKX6.1 expression domain. We make analogous observations about FOXA binding during hepatic and lung development. Our findings suggest a dual role for FOXA in endodermal organ development: first, FOXA facilitates signal-dependent lineage initiation via enhancer priming, and second, FOXA enforces organ cell type-specific gene expression via indirect recruitment by lineage-specific TFs.

Identifiants

pubmed: 34789735
doi: 10.1038/s41467-021-26950-0
pii: 10.1038/s41467-021-26950-0
pmc: PMC8599738
doi:

Substances chimiques

FOXA1 protein, human 0
FOXA2 protein, human 0
Hepatocyte Nuclear Factor 3-alpha 0
Homeodomain Proteins 0
NKX6-1 protein, human 0
Trans-Activators 0
pancreatic and duodenal homeobox 1 protein 0
Hepatocyte Nuclear Factor 3-beta 135845-92-0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6636

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK063491
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008666
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK068471
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK078803
Pays : United States
Organisme : NIDDK NIH HHS
ID : U54 DK107977
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL095993
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128172
Pays : United States
Organisme : NCATS NIH HHS
ID : U01 TR001810
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

Wang, A. et al. Epigenetic priming of enhancers predicts developmental competence of hESC-derived endodermal lineage intermediates. Cell Stem Cell 16, 386–399 (2015).
pubmed: 25842977 pmcid: 4478079 doi: 10.1016/j.stem.2015.02.013
Zorn, A. M. & Wells, J. M. Vertebrate endoderm development and organ formation. Annu. Rev. Cell Dev. Biol. 25, 221–251 (2009).
pubmed: 19575677 pmcid: 2861293 doi: 10.1146/annurev.cellbio.042308.113344
Lee, K. et al. FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation. Cell Rep. 28, 382–393 e387 (2019).
pubmed: 31291575 pmcid: 6636862 doi: 10.1016/j.celrep.2019.06.034
Genga, R. M. J. et al. Single-cell RNA-sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development. Cell Rep. 27, 708–718 e710 (2019).
pubmed: 30995470 pmcid: 6525305 doi: 10.1016/j.celrep.2019.03.076
Wan, H. et al. Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis. J. Biol. Chem. 280, 13809–13816 (2005).
pubmed: 15668254 doi: 10.1074/jbc.M414122200
Lee, C. S., Friedman, J. R., Fulmer, J. T. & Kaestner, K. H. The initiation of liver development is dependent on Foxa transcription factors. Nature 435, 944–947 (2005).
pubmed: 15959514 doi: 10.1038/nature03649
Iwafuchi-Doi, M. et al. The pioneer transcription factor FoxA maintains an accessible nucleosome configuration at enhancers for tissue-specific gene activation. Mol. Cell 62, 79–91 (2016).
pubmed: 27058788 pmcid: 4826471 doi: 10.1016/j.molcel.2016.03.001
Soufi, A. et al. Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Cell 161, 555–568 (2015).
pubmed: 25892221 pmcid: 4409934 doi: 10.1016/j.cell.2015.03.017
Cirillo, L. A. et al. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 9, 279–289 (2002).
pubmed: 11864602 doi: 10.1016/S1097-2765(02)00459-8
Carroll, J. S. et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122, 33–43 (2005).
pubmed: 16009131 doi: 10.1016/j.cell.2005.05.008
Gualdi, R. et al. Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes Dev. 10, 1670–1682 (1996).
pubmed: 8682297 doi: 10.1101/gad.10.13.1670
Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D. & Carroll, J. S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet 43, 27–33 (2011).
pubmed: 21151129 doi: 10.1038/ng.730
Magnani, L. & Lupien, M. Chromatin and epigenetic determinants of estrogen receptor alpha (ESR1) signaling. Mol. Cell Endocrinol. 382, 633–641 (2014).
pubmed: 23684889 doi: 10.1016/j.mce.2013.04.026
Wang, Q. et al. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138, 245–256 (2009).
pubmed: 19632176 pmcid: 2726827 doi: 10.1016/j.cell.2009.04.056
Lupien, M. et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132, 958–970 (2008).
pubmed: 18358809 pmcid: 2323438 doi: 10.1016/j.cell.2008.01.018
Caizzi, L. et al. Genome-wide activity of unliganded estrogen receptor-alpha in breast cancer cells. Proc. Natl Acad. Sci. USA 111, 4892–4897 (2014).
pubmed: 24639548 pmcid: 3977241 doi: 10.1073/pnas.1315445111
Donaghey, J. et al. Genetic determinants and epigenetic effects of pioneer-factor occupancy. Nat. Genet 50, 250–258 (2018).
pubmed: 29358654 pmcid: 6517675 doi: 10.1038/s41588-017-0034-3
Swinstead, E. E. et al. Steroid receptors reprogram FoxA1 occupancy through dynamic chromatin transitions. Cell 165, 593–605 (2016).
pubmed: 27062924 pmcid: 4842147 doi: 10.1016/j.cell.2016.02.067
Zhang, Y. et al. GENE REGULATION. Discrete functions of nuclear receptor Rev-erbalpha couple metabolism to the clock. Science 348, 1488–1492 (2015).
pubmed: 26044300 pmcid: 4613749 doi: 10.1126/science.aab3021
Paakinaho, V., Swinstead, E. E., Presman, D. M., Grontved, L. & Hager, G. L. Meta-analysis of chromatin programming by steroid receptors. Cell Rep. 28, 3523–3534 e3522 (2019).
pubmed: 31553919 pmcid: 6914262 doi: 10.1016/j.celrep.2019.08.039
Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307–319 (2013).
pubmed: 23582322 pmcid: 3653129 doi: 10.1016/j.cell.2013.03.035
Kobberup, S., Nyeng, P., Juhl, K., Hutton, J. & Jensen, J. ETS-family genes in pancreatic development. Dev. Dyn. 236, 3100–3110 (2007).
pubmed: 17907201 doi: 10.1002/dvdy.21292
Mamidi, A. et al. Mechanosignalling via integrins directs fate decisions of pancreatic progenitors. Nature 564, 114–118 (2018).
pubmed: 30487608 doi: 10.1038/s41586-018-0762-2
Huang, W. et al. Retinoic acid plays an evolutionarily conserved and biphasic role in pancreas development. Dev. Biol. 394, 83–93 (2014).
pubmed: 25127993 pmcid: 4623430 doi: 10.1016/j.ydbio.2014.07.021
Cebola, I. et al. TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors. Nat. Cell Biol. 17, 615–626 (2015).
pubmed: 25915126 pmcid: 4434585 doi: 10.1038/ncb3160
Farley, E. K. et al. Suboptimization of developmental enhancers. Science 350, 325–328 (2015).
pubmed: 26472909 pmcid: 4970741 doi: 10.1126/science.aac6948
Fornes, O. et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 48, D87–D92 (2020).
pubmed: 31701148
Sung, M. H., Guertin, M. J., Baek, S. & Hager, G. L. DNase footprint signatures are dictated by factor dynamics and DNA sequence. Mol. Cell 56, 275–285 (2014).
pubmed: 25242143 pmcid: 4272573 doi: 10.1016/j.molcel.2014.08.016
Veres, A. et al. Charting cellular identity during human in vitro beta-cell differentiation. Nature 569, 368–373 (2019).
pubmed: 31068696 pmcid: 6903417 doi: 10.1038/s41586-019-1168-5
Schaffer, A. E. et al. Nkx6.1 controls a gene regulatory network required for establishing and maintaining pancreatic Beta cell identity. PLoS Genet. 9, e1003274 (2013).
pubmed: 23382704 pmcid: 3561089 doi: 10.1371/journal.pgen.1003274
Jacob, A. et al. Differentiation of human pluripotent stem cells into functional lung alveolar epithelial cells. Cell Stem Cell 21, 472–488 e410 (2017).
pubmed: 28965766 pmcid: 5755620 doi: 10.1016/j.stem.2017.08.014
Corso-Diaz, X. et al. Co-activator candidate interactions for orphan nuclear receptor NR2E1. BMC Genomics 17, 832 (2016).
pubmed: 27782803 pmcid: 5080790 doi: 10.1186/s12864-016-3173-5
Kheolamai, P. & Dickson, A. J. Liver-enriched transcription factors are critical for the expression of hepatocyte marker genes in mES-derived hepatocyte-lineage cells. BMC Mol. Biol. 10, 35 (2009).
pubmed: 19389256 pmcid: 2680860 doi: 10.1186/1471-2199-10-35
Papaioannou, V. E. The T-box gene family: emerging roles in development, stem cells and cancer. Development 141, 3819–3833 (2014).
pubmed: 25294936 pmcid: 4197708 doi: 10.1242/dev.104471
Ramana, C. V. Insights into the signal transduction pathways of mouse lung type II cells revealed by transcription factor profiling in the transcriptome. Genomics Inf. 17, e8 (2019).
doi: 10.5808/GI.2019.17.1.e8
Ikonomou, L. et al. The in vivo genetic program of murine primordial lung epithelial progenitors. Nat. Commun. 11, 635 (2020).
pubmed: 32005814 pmcid: 6994558 doi: 10.1038/s41467-020-14348-3
Herriges, M. & Morrisey, E. E. Lung development: orchestrating the generation and regeneration of a complex organ. Development 141, 502–513 (2014).
pubmed: 24449833 pmcid: 3899811 doi: 10.1242/dev.098186
Zaret, K. S. & Carroll, J. S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25, 2227–2241 (2011).
pubmed: 22056668 pmcid: 3219227 doi: 10.1101/gad.176826.111
Crocker, J. et al. Low affinity binding site clusters confer hox specificity and regulatory robustness. Cell 160, 191–203 (2015).
pubmed: 25557079 doi: 10.1016/j.cell.2014.11.041
Li, L. C. et al. Single-cell transcriptomic analyses reveal distinct dorsal/ventral pancreatic programs. EMBO Rep. 19, https://doi.org/10.15252/embr.201846148 (2018).
Brissova, M. et al. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J. Histochem. Cytochem. 53, 1087–1097 (2005).
pubmed: 15923354 doi: 10.1369/jhc.5C6684.2005
Xie, R. et al. Dynamic chromatin remodeling mediated by polycomb proteins orchestrates pancreatic differentiation of human embryonic stem cells. Cell Stem Cell 12, 224–237 (2013).
pubmed: 23318056 pmcid: 3619036 doi: 10.1016/j.stem.2012.11.023
Schulz, T. C. et al. A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS ONE 7, e37004 (2012).
pubmed: 22623968 pmcid: 3356395 doi: 10.1371/journal.pone.0037004
Rezania, A. et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat. Biotechnol. 32, 1121–1133 (2014).
pubmed: 25211370 doi: 10.1038/nbt.3033
Jin, W. et al. A network of microRNAs acts to promote cell cycle exit and differentiation of human pancreatic endocrine cells. Iscience 21, 681–694 (2019).
pubmed: 31733514 pmcid: 6889369 doi: 10.1016/j.isci.2019.10.063
Hurley, K. et al. Reconstructed single-cell fate trajectories define lineage plasticity windows during differentiation of human PSC-derived distal lung progenitors. Cell Stem Cell 26, 593–608 e598 (2020).
pubmed: 32004478 pmcid: 7469703 doi: 10.1016/j.stem.2019.12.009
Jacob, A. et al. Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells. Nat. Protoc. 14, 3303–3332 (2019).
pubmed: 31732721 pmcid: 7275645 doi: 10.1038/s41596-019-0220-0
Hawkins, F. et al. Prospective isolation of NKX2-1-expressing human lung progenitors derived from pluripotent stem cells. J. Clin. Invest. 127, 2277–2294 (2017).
pubmed: 28463226 pmcid: 5451263 doi: 10.1172/JCI89950
Maddalo, D. et al. In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature 516, 423–427 (2014).
pubmed: 25337876 pmcid: 4270925 doi: 10.1038/nature13902
Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281–2308 (2013).
pubmed: 24157548 pmcid: 3969860 doi: 10.1038/nprot.2013.143
Rubinson, D. A. et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33, 401–406 (2003).
pubmed: 12590264 doi: 10.1038/ng1117
Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996–1006 (2002).
pubmed: 12045153 pmcid: 186604 doi: 10.1101/gr.229102
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
pubmed: 19451168 pmcid: 2705234 doi: 10.1093/bioinformatics/btp324
Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
pubmed: 19505943 pmcid: 2723002 doi: 10.1093/bioinformatics/btp352
Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576–589 (2010).
pubmed: 20513432 pmcid: 2898526 doi: 10.1016/j.molcel.2010.05.004
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
pubmed: 20110278 pmcid: 2832824 doi: 10.1093/bioinformatics/btq033
Ramirez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160–W165 (2016).
pubmed: 27079975 pmcid: 4987876 doi: 10.1093/nar/gkw257
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511–515 (2010).
pubmed: 20436464 pmcid: 3146043 doi: 10.1038/nbt.1621
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213–1218 (2013).
pubmed: 24097267 pmcid: 3959825 doi: 10.1038/nmeth.2688
Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
pubmed: 18798982 pmcid: 2592715 doi: 10.1186/gb-2008-9-9-r137
Geusz, R. J. et al. Pancreatic progenitor epigenome maps prioritize type 2 diabetes risk genes with roles in development. Elife 10, https://doi.org/10.7554/eLife.59067 (2021).
Durand, N. C. et al. Juicebox provides a visualization system for Hi-C contact maps with unlimited zoom. Cell Syst. 3, 99–101 (2016).
pubmed: 27467250 pmcid: 5596920 doi: 10.1016/j.cels.2015.07.012
Rao, S. S. et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159, 1665–1680 (2014).
pubmed: 25497547 pmcid: 5635824 doi: 10.1016/j.cell.2014.11.021
Zheng, G. X. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).
pubmed: 28091601 pmcid: 5241818 doi: 10.1038/ncomms14049
Stuart, T. et al. Comprehensive Integration of Single-Cell Data. Cell 177, 1888–1902 e1821 (2019).
pubmed: 31178118 pmcid: 6687398 doi: 10.1016/j.cell.2019.05.031
McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495–501 (2010).
pubmed: 20436461 pmcid: 4840234 doi: 10.1038/nbt.1630
Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).
pubmed: 30944313 pmcid: 6447622 doi: 10.1038/s41467-019-09234-6
Loven, J. et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320–334 (2013).
pubmed: 23582323 pmcid: 3760967 doi: 10.1016/j.cell.2013.03.036
Grant, C. E., Bailey, T. L. & Noble, W. S. FIMO: scanning for occurrences of a given motif. Bioinformatics 27, 1017–1018 (2011).
pubmed: 21330290 pmcid: 3065696 doi: 10.1093/bioinformatics/btr064
Bailey, T. L. & Machanick, P. Inferring direct DNA binding from ChIP-seq. Nucleic Acids Res. 40, e128 (2012).
pubmed: 22610855 pmcid: 3458523 doi: 10.1093/nar/gks433
Aylward, A., Chiou, J., Okino, M. L., Kadakia, N. & Gaulton, K. J. Shared genetic risk contributes to type 1 and type 2 diabetes etiology. Hum. Mol. Genet., https://doi.org/10.1093/hmg/ddy314 (2018).
Rozowsky, J. et al. AlleleSeq: analysis of allele-specific expression and binding in a network framework. Mol. Syst. Biol. 7, 522 (2011).
pubmed: 21811232 pmcid: 3208341 doi: 10.1038/msb.2011.54
Mathelier, A. et al. JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 44, D110–D115 (2016).
pubmed: 26531826 doi: 10.1093/nar/gkv1176
Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).
doi: 10.1038/nature11247
Pique-Regi, R. et al. Accurate inference of transcription factor binding from DNA sequence and chromatin accessibility data. Genome Res. 21, 447–455 (2011).
pubmed: 21106904 pmcid: 3044858 doi: 10.1101/gr.112623.110
Dekker, J. et al. The 4D nucleome project. Nature 549, 219–226 (2017).
pubmed: 28905911 pmcid: 5617335 doi: 10.1038/nature23884

Auteurs

Ryan J Geusz (RJ)

Department of Pediatrics, Pediatric Diabetes Research Center, University of California, La Jolla, San Diego, CA, 92093, USA.
Department of Cellular & Molecular Medicine, University of California, La Jolla, San Diego, CA, 92093, USA.
Sanford Consortium for Regenerative Medicine, La Jolla, San Diego, CA, 92093, USA.
Biomedical Graduate Studies Program, University of California San Diego, La Jolla, San Diego, CA, 92037, USA.

Allen Wang (A)

Department of Pediatrics, Pediatric Diabetes Research Center, University of California, La Jolla, San Diego, CA, 92093, USA.
Department of Cellular & Molecular Medicine, University of California, La Jolla, San Diego, CA, 92093, USA.
Sanford Consortium for Regenerative Medicine, La Jolla, San Diego, CA, 92093, USA.

Dieter K Lam (DK)

Department of Pediatrics, Pediatric Diabetes Research Center, University of California, La Jolla, San Diego, CA, 92093, USA.
Department of Cellular & Molecular Medicine, University of California, La Jolla, San Diego, CA, 92093, USA.
Sanford Consortium for Regenerative Medicine, La Jolla, San Diego, CA, 92093, USA.

Nicholas K Vinckier (NK)

Department of Pediatrics, Pediatric Diabetes Research Center, University of California, La Jolla, San Diego, CA, 92093, USA.
Department of Cellular & Molecular Medicine, University of California, La Jolla, San Diego, CA, 92093, USA.
Sanford Consortium for Regenerative Medicine, La Jolla, San Diego, CA, 92093, USA.

Konstantinos-Dionysios Alysandratos (KD)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.
The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA, 02118, USA.

David A Roberts (DA)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.

Jinzhao Wang (J)

Department of Pediatrics, Pediatric Diabetes Research Center, University of California, La Jolla, San Diego, CA, 92093, USA.
Department of Cellular & Molecular Medicine, University of California, La Jolla, San Diego, CA, 92093, USA.
Sanford Consortium for Regenerative Medicine, La Jolla, San Diego, CA, 92093, USA.

Samy Kefalopoulou (S)

Department of Pediatrics, Pediatric Diabetes Research Center, University of California, La Jolla, San Diego, CA, 92093, USA.
Department of Cellular & Molecular Medicine, University of California, La Jolla, San Diego, CA, 92093, USA.
Sanford Consortium for Regenerative Medicine, La Jolla, San Diego, CA, 92093, USA.

Araceli Ramirez (A)

Department of Pediatrics, Pediatric Diabetes Research Center, University of California, La Jolla, San Diego, CA, 92093, USA.
Department of Cellular & Molecular Medicine, University of California, La Jolla, San Diego, CA, 92093, USA.
Sanford Consortium for Regenerative Medicine, La Jolla, San Diego, CA, 92093, USA.

Yunjiang Qiu (Y)

Department of Cellular & Molecular Medicine, University of California, La Jolla, San Diego, CA, 92093, USA.

Joshua Chiou (J)

Department of Pediatrics, Pediatric Diabetes Research Center, University of California, La Jolla, San Diego, CA, 92093, USA.
Biomedical Graduate Studies Program, University of California San Diego, La Jolla, San Diego, CA, 92037, USA.

Kyle J Gaulton (KJ)

Department of Pediatrics, Pediatric Diabetes Research Center, University of California, La Jolla, San Diego, CA, 92093, USA.

Bing Ren (B)

Department of Cellular & Molecular Medicine, University of California, La Jolla, San Diego, CA, 92093, USA.
Ludwig Institute for Cancer Research, La Jolla, San Diego, CA, 92093-0653, USA.

Darrell N Kotton (DN)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.
The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA, 02118, USA.

Maike Sander (M)

Department of Pediatrics, Pediatric Diabetes Research Center, University of California, La Jolla, San Diego, CA, 92093, USA. masander@ucsd.edu.
Department of Cellular & Molecular Medicine, University of California, La Jolla, San Diego, CA, 92093, USA. masander@ucsd.edu.
Sanford Consortium for Regenerative Medicine, La Jolla, San Diego, CA, 92093, USA. masander@ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH